Related Experiment Video
Updated: Jun 21, 2026

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
Published on: March 6, 2018
Hormone therapy and cancer risks in transgender people: a systematic review
Liza Yurie Teruya Uchimura1, Tatiana Yonekura1, Mabel Fernandes Figueiró1
1Hospital do Coração, São Paulo, SP, Brazil.
Objective:
To identify the available evidence on the risk of developing cancer in transgender people undergoing hormone therapy.
Methods:
This was a rapid systematic review conducted in the PubMed, Embase, Virtual Health Library, Cochrane Library and Epistemonikos databases. Screening and data extraction were performed by independent reviewers using the Rayyan platform. Data extraction was carried out by 3 independent reviewers. We used the Joanna Briggs Institute checklists specific to cohort and case-control studies to assess the methodological quality of the included studies.
Results:
Five studies were included, 4 cohort studies and 1 case-control. The risk of transgender people developing cancer while on hormone therapy was identified by 2 studies and not identified in 3 studies.
Conclusion:
Despite studies with large sample sizes and rigorous selection criteria, the literature does not present a consensus on the association between hormone therapy and the development of cancer in transgender people.
Related Concept Videos
Hormonal Regulation
Internal Receptors
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Disorders of the Female Reproductive System
Hazard Ratio
For example, in a clinical trial...

